featured
ESMO: Niraparib in Patients With Newly Diagnosed Advanced Ovarian Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles: